Company:Avantor

From HandWiki
Revision as of 19:45, 9 February 2024 by Rtexter1 (talk | contribs) (change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: U.S. chemical company
Avantor, Inc.
TypePublic company
IndustryBiotechnology
Chemicals
Pharmaceuticals[1][2]
Founded1904; 120 years ago (1904)
HeadquartersRadnor, Pennsylvania, U.S.
Key people
Michael Stubblefield, CEO and President
Brands
  • VWR International
  • J.T. Baker
OwnerNew Mountain Capital (10%)
Funds advised by Goldman Sachs (13%) [3]
Number of employees
12,400 (2020)
Websiteavantorsciences.com


Avantor is an American biotechnology, chemicals, and pharmaceuticals company headquartered in Radnor, Pennsylvania. The company ranked 484th on the 2020 Fortune 500 ,[4] based on its 2019 sales.

History

In 1904, John Townsend Baker founded the chemical company J.T. Baker. The company was acquired by Procter & Gamble in 1985, and was subsequently sold to Mallinckrodt in 1995.

In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor.[5] The company expanded globally with the 2011 acquisitions of Indian laboratory reagents supplier RFCL and Polish lab supply firm POCH.[6]

In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.[7]

In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. This was the second biggest initial public offering of the year.[5] That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy.[8] In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.[9]

In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications. Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.[10]

COVID-19

During the COVID19 pandemic, Avantor continuously supplied medical-grade and FDA-compliant silicone technology that meets device manufacturers' unique production needs.[11]

In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.[12][13]

Industries

Avantor provides products and services to the biopharma, healthcare, education and government, advanced technologies, and applied materials industries.[1][2] The company has more than 6 million different products.[13]

Avantor's NuSil brand provides silicone for long-term implantable devices, including high-purity silicone adhesives and lubricious[clarification needed] silicones. A dispensing system developed by NuSil injects pre-sterilized silicone directly into the body, allowing the material to conform to the patient's anatomy and cure into its final form, creating a custom-fit device.[11]

Controversies

On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic.[14] According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available.[15] In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride.[16] Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”[17]

References

  1. 1.0 1.1 Avantor Inc., Bloomberg, https://www.bloomberg.com/profile/company/AVTR:US, retrieved September 1, 2021 
  2. 2.0 2.1 Avantor Inc., The Wall Street Journal, https://www.wsj.com/market-data/quotes/AVTR/company-people, retrieved September 1, 2021 
  3. SEC Report
  4. Fortune .com
  5. 5.0 5.1 Hytha, Michael; Cortez, Michelle Fay (16 May 2019). "Avantor Gets Modest Trade Debut Bump After $2.9 Billion IPO". Bloomberg News. https://www.bloomberg.com/news/articles/2019-05-17/avantor-raises-2-9-billion-in-year-s-second-biggest-ipo. 
  6. Reisch, Marc S. (17 November 2014). "Separating From A Corporate Parent". https://cen.acs.org/articles/92/i46/Separating-Corporate-Parent.html. 
  7. Harris, Jon. "Center Valley's Avantor involved in $6.4B deal that could create Fortune 500 company" (in en-US). Lehigh Valley Business Cycle. http://www.mcall.com/business/mc-avantor-acquiring-vwr-20170505-story.html. 
  8. Avantor opens customer support centre in Shanghai, BioSpectrum Asia, December 12, 2019, https://www.biospectrumasia.com/news/28/15057/avantor-opens-customer-support-centre-in-shanghai.html, retrieved September 18, 2021 
  9. Avantor Expands Life Sciences Innovation Center, Genetic Engineering & Biotechnology News, July 9, 2020, https://www.genengnews.com/topics/drug-discovery/avantor-expands-life-sciences-innovation-center/, retrieved September 28, 2021 
  10. Stanton, Dan (June 2, 2021), Avantor boosts single-use production with RIM buy, BioProcess International, https://bioprocessintl.com/bioprocess-insider/upstream-downstream-processing/avantor-boosts-single-use-production-with-rim-buy/, retrieved September 1, 2021 
  11. 11.0 11.1 Hagerty, Hayley (1 April 2021). "How Medical-Grade Silicone Is Advancing Reliable Patient Care". https://www.plasticstoday.com/medical/how-medical-grade-silicone-advancing-reliable-patient-care. 
  12. Dalton, Matthew; Walker, Joseph (19 December 2020). "Covid-19 Vaccine Makers Tap Contractors to Produce Billions of Doses". The Wall Street Journal. https://www.wsj.com/articles/covid-19-vaccine-makers-tap-contractors-to-produce-billions-of-doses-11608373800. 
  13. 13.0 13.1 "How Avantor helps in the vaccine supply chain". CNBC. 21 December 2020. https://www.cnbc.com/video/2020/12/21/how-avantor-helps-in-the-vaccine-supply-chain.html?&qsearchterm=avantor. 
  14. "Heroin's Hidden Ingredient Is a Chemical Made by U.S. Companies" (in en). Bloomberg.com. 2020-08-26. https://www.bloomberg.com/news/features/2020-08-26/u-s-drug-crisis-is-made-in-mexico-with-american-raw-materials. 
  15. Smith, Michael. "Avantor Stops Sale of Chemical in Mexico Used to Make Heroin" (in en). https://www.bloombergquint.com/onweb/avantor-stops-sales-of-chemical-in-mexico-used-to-make-heroin. 
  16. Simpson, Cam. "Politics Could Imperil Probe of Narco Access to U.S. Chemicals" (in en). https://www.bloombergquint.com/business/politics-could-imperil-probe-of-narco-access-to-u-s-chemicals. 
  17. "Republican Senators Urge Investigation of Avantor" (in en-US). 2021-04-15. https://www.nationalreview.com/bench-memos/republican-senators-urge-investigation-of-avantor/. 

External links